Drug Profile
Aliskiren/amlodipine - Novartis
Alternative Names: Amlodipine/aliskiren; Rasilamlo; Rasilez Amlo; SPA 100; TekamloLatest Information Update: 11 Feb 2019
Price :
$50
*
At a glance
- Originator Novartis
- Class Amides; Antihypertensives; Dihydropyridines; Fumarates; Small molecules
- Mechanism of Action Calcium channel antagonists; Renin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension
Most Recent Events
- 11 Feb 2019 Chemical structure information added
- 11 Mar 2015 Launched for Hypertension in Argentina, Brazil, Austria, Ireland, Portugal, Poland, Switzerland and India (PO) before March 2015
- 28 Mar 2014 Launched prior to March 2014 for Hypertension in Czech Republic, Italy and Netherlands (PO)